Bayesian Capital Management’s Air Products & Chemicals APD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82M Buy
+6,200
New +$1.8M 1.16% 14
2025
Q4
Sell
-11,526
Closed -$3.14M 136
2025
Q3
$3.14M Buy
+11,526
New +$3.34M 0.64% 24
2025
Q2
Sell
-8,000
Closed -$2.36M 536
2025
Q1
$2.36M Buy
+8,000
New +$2.47M 0.39% 69
2023
Q1
Sell
-1,762
Closed -$543K 765
2022
Q4
$543K Buy
+1,762
New +$497K 0.08% 332
2022
Q1
Sell
-2,826
Closed -$860K 767
2021
Q4
$860K Buy
+2,826
New +$830K 0.27% 113
2020
Q3
Sell
-2,900
Closed -$700K 513
2020
Q2
$700K Buy
+2,900
New +$662K 0.15% 188
2018
Q1
Sell
-13,300
Closed -$2.18M 574
2017
Q4
$2.18M Sell
13,300
-1,800
-12% -$287K 0.44% 40
2017
Q3
$2.28M Buy
+15,100
New +$2.21M 0.55% 32

Other funds holding APD

Bayesian Capital Management's APD Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in Air Products & Chemicals (APD) in Q2 2026: 6,200 shares worth $1.82M. The stake represents 1.16% of the portfolio and ranks #14 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in APD as recently as Q3 2025.

Bayesian Capital Management first reported a position in APD in Q3 2017 and has held it in 8 quarters since. The position peaked at $3.14M in Q3 2025. 1,770 funds tracked by Wall St. Rank hold APD as of Q2 2026.

  • Bayesian Capital Management held 6,200 shares of Air Products & Chemicals worth $1.82M as of Q2 2026.
  • Air Products & Chemicals was a new Bayesian Capital Management position in Q2 2026.
  • Air Products & Chemicals made up 1.16% of Bayesian Capital Management's portfolio in Q2 2026, its #14 holding.
  • Bayesian Capital Management first reported a position in Air Products & Chemicals in Q3 2017 and has held it in 8 quarters since.
  • Bayesian Capital Management's Air Products & Chemicals position peaked at $3.14M in Q3 2025.
  • 1,770 funds tracked by Wall St. Rank held Air Products & Chemicals as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.